Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

Ana RuigómezTania SchinkAnnemarie VossRon M C HeringsElisabeth SmitsKarin Swart-PolinderYanina BalabanovaGunnar BrobertKiliana Suzart-WoischnikLuis Alberto García Rodríguez

Published in: PloS one (2024)

This study provides further data from routine clinical practice that broadly support safety profile of rivaroxaban for VTE indication and complement findings from previous randomized clinical trials.

Keyphrases

venous thromboembolism
clinical practice
direct oral anticoagulants
electronic health record
atrial fibrillation
machine learning
deep learning
data analysis